Brief Telehealth Cognitive Rehabilitation Following Mild TBI (On-TRACC)

Brief Telehealth Cognitive Rehabilitation Following Mild Traumatic Brain Injury: A Pilot Study

In the United States, more than a million people sustain a mild traumatic brain injury (mTBI) every year. Although many recover fully, emerging literature suggests a high number of individuals report chronic, and functionally disabling, cognitive difficulties. Among Veterans, a nationwide survey found that more than 75% of 55,000 Veterans with a history of mTBI reported persistent moderate to severe levels of forgetfulness and poor concentration.

Reduced cognitive functioning following mTBI contributes to significant functional impairment, including underemployment, relationship difficulties, and reduced community integration for years post injury. Despite the significant individual and societal impact, evidence to guide interventions and treatment for this population remains limited. Even more limited are validated telehealth options for these symptoms, a critical means by which access to care can be improved, especially during the COVID-19 pandemic. The proposed pilot study will address this gap by evaluating the feasibility, acceptability, and preliminary effectiveness of a brief (5-session) cognitive rehabilitation intervention that was developed for individuals with mTBI and that will be administered over video-based telehealth technology. The development of this intervention was supported by a grant from the Department of Defense, with critical elements identified through surveys completed by clinicians and veterans with a history of mTBI, and also the clinical expertise of the team.

Study Overview

• Status: Completed
• Conditions: Cognitive Impairment; Mild Traumatic Brain Injury
• Intervention / Treatment: Behavioral: Brief Cognitive Rehabilitation

• Study Type: Interventional
• Enrollment (Actual): 28
• Phase: Not Applicable

Contacts and Locations

Study Locations

• United States
  • Washington
    • Seattle, Washington, United States, 98108
      • VA Puget Sound Health Care System

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

Description

Inclusion Criteria:

• Age 18+;
• Read, speak, understand English;
• History of at least one mTBI;
• Endorses moderate to severe cognitive difficulties in one or more of Neurobehavioral Symptom Inventory items M-P;
• Ability and willingness to participate in audio recorded sessions over video telehealth platform in a private setting, including equipment and internet access;
• Lives within 2 hours of VA Puget Sound or affiliated clinics/University of Washington;
• Will be in Washington State when engaging in treatment sessions

Exclusion Criteria:

• Significant cognitive impairment that would limit ability to engage on treatment;
• Neurologic injury or illness that affects cognitive functioning, including history of moderate or severe TBI;
• History of TBI in the past 3 months, from the date of screening;
• History of serious mental illness involving psychotic symptoms;
• Current psychotic or manic symptoms;
• Current or active flag, or documentation in medical record, for behavior or suicide risk;
• Current (within the past 3 months) Substance Use Disorder (not including caffeine or nicotine disorder)

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: Brief Cognitive Rehabilitation; 5-session Cognitive Rehabilitation intervention administered over telehealth	Behavioral: Brief Cognitive Rehabilitation; 5-session Cognitive Rehabilitation intervention that can be administered over telehealth.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Feasibility of administering the On-TRACC intervention to individuals with mTBI	Feasibility measures will include rate of enrollment of eligible individuals as well as dropout rate for enrolled participants. We will also evaluate participant adherence, including proportion of treatment sessions attended and number of days that homework was completed.	At the completion of 5 week intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Participant satisfaction with On-TRACC intervention	Participants will provide feedback on individual treatment sessions and at the end of treatment regarding intervention content. Participants will complete a Weekly Therapy Rating form after each treatment session and an End of Treatment Patient Feedback Form at the end of treatment to provide satisfaction ratings.	End of each treatment session and at treatment completion, 5 weeks total.
Preliminary effectiveness of On-TRACC intervention in decreasing post-concussive symptoms	Pre-post treatment change in post-concussive symptoms (Neurobehavioral Symptom Inventory) will be evaluated.	Baseline (pre-treatment) and at the end of the 5-week On-TRACC intervention, 5 week time-frame on average
Preliminary effectiveness of On-TRACC intervention at decreasing self-reported cognitive difficulties	Pre-post treatment change in self-reported cognitive difficulties (NeuroQol Item Bank Cognitive Function SF) will be evaluated.	Baseline (pre-treatment) and at the end of the 5-week On-TRACC intervention, 5 week time-frame on average
Preliminary effectiveness of On-TRACC intervention at improving self-efficacy	Pre-post treatment change in self-efficacy (Cognitive Concerns Self-Efficacy Scale) will be evaluated.	Baseline (pre-treatment) and at the end of the 5-week On-TRACC intervention, 5 week time-frame on average

Collaborators and Investigators

• Sponsor: University of Washington
• Collaborators: VA Puget Sound Health Care System
• Investigators: Principal Investigator: Kathleen Pagulayan, PhD, VA Puget Sound Health Care System/University of Washington

Study record dates

Study Major Dates

• Study Start (Actual): December 13, 2021
• Primary Completion (Actual): October 10, 2022
• Study Completion (Actual): October 13, 2022

Study Registration Dates

• First Submitted: December 13, 2021
• First Submitted That Met QC Criteria: April 2, 2022
• First Posted (Actual): April 7, 2022

Study Record Updates

• Last Update Posted (Actual): March 24, 2023
• Last Update Submitted That Met QC Criteria: March 22, 2023
• Last Verified: March 1, 2023

More Information

Terms related to this study

• Additional Relevant MeSH Terms: Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Wounds and Injuries; Craniocerebral Trauma; Trauma, Nervous System; Head Injuries, Closed; Wounds, Nonpenetrating; Brain Injuries; Brain Injuries, Traumatic; Brain Concussion
• Other Study ID Numbers: STUDY00013494

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No